It has been found that PD-1 ligand (PD-L1), also known as B7H1 or CD274, is overexpressed on CSCs from CRC (35–37), head and neck squamous cell carcinoma (38), and gastric cancer (39), contributing to immune evasion of CSCs (40). Here, CD274 is linked to colorectal carcinoma.